Immusoft Corp
Biotechnology company · Seattle, Washington, United States
Immusoft Corp is a biotechnology company headquartered in Seattle, Washington, United States. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $4.4 million in total, most recently in 2020. It has reported private securities offerings to the US SEC, most recently $375,000 sold in a notice filed in 2015.
Immusoft at a glance
What does Immusoft do?
US government research funding
3 SBIR/STTR small-business research awards from US health agencies, $4.4 million in total (2012 to 2020). NIH funding came from the National Institute of General Medical Sciences, National Institute of Neurological Disorders and Stroke.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $375,000 sold (2015).
Frequently asked questions about Immusoft
Where is Immusoft headquartered?
Immusoft Corp is headquartered in Seattle, Washington, United States.
What does Immusoft do?
Immusoft Corp is a biotechnology company.
Similar companies
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Kineta, Inc.Seattle, Washington, United States
- Avm Biotechnology, LLCSeattle, Washington, United States
- Lumen Bioscience, Inc.Seattle, Washington, United States
- Presage Biosciences, Inc.Seattle, Washington, United States
- Sana Biotechnology, Inc.Seattle, Washington, United States
- Phase Genomics, Inc.Seattle, Washington, United States
- Soovu Labs, Inc.Seattle, Washington, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences